Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Seattle Genetics Inc patents

Recent patent applications related to Seattle Genetics Inc. Seattle Genetics Inc is listed as an Agent/Assignee. Note: Seattle Genetics Inc may have other listings under different names/spellings. We're not affiliated with Seattle Genetics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Seattle Genetics Inc-related inventors




Date Seattle Genetics Inc patents (updated weekly) - BOOKMARK this page
08/31/17Targeted delivery of tertiary amine-containing drug substances
08/17/17Cyclodextrin and antibody-drug conjugate formulations
08/17/17Bcma antibodies and use of same to treat cancer and immunological disorders
08/03/17Hydrophilic antibody-drug conjugates
07/20/17Cd33 antibodies and use of same to treat cancer
07/06/17Beta-glucuronide-linker drug conjugates
07/06/17Beta-glucuronide-linker drug conjugates
06/29/17Optimal dosing of a cd19-antibody drug conjugate
06/08/17Preparing antibodies from cho cell cultures for conjugation
05/25/17Targeted pyrrolobenzodiazapine conjugates
05/18/17Dosage and administration of non-fucosylated anti-cd40 antibodies
02/09/17Methods of inhibition of protein fucosylation in vivo using fucose analogs
02/02/17Stable formulations for anti-cd19 antibodies and antibody-drug conjugates
01/26/17Humanized anti-cd70 binding agents and uses thereof
01/05/17Monomethylvaline compounds capable of conjugation to ligands
12/29/16Antibodies to integrin avb6 and use of same to treat cancer
12/22/16Variant target binding agents and uses thereof
12/22/16Antibody drug conjugates (adc) that bind to 158p1d7 proteins
12/15/16Beta-glucuronide-linker drug conjugates
12/01/16Selective reduction of proteins
10/27/16Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
10/20/16Methylene carbamate linkers for use with targeted-drug conjugates
10/06/16Pyrrolobenzodiazepines and targeted conjugates
10/06/16Pyrrolobenzodiazepines and targeted conjugates
09/15/16Antibody drug conjugates (adc) that bind to 191p4d12 proteins
08/04/16Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mtor pathway
07/07/16New binder-drug conjugates (adcs) and use thereof
06/30/16Humanized antibodies to liv-1 and use of same to treat cancer
05/12/16Targeted pyrrolobenzodiazapine conjugates
05/12/16Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
02/18/16Cyclodextrin and antibody-drug conjugate formulations
02/11/16Activated carbon filtration for purification of benzodiazepine adcs
01/14/16Antibodies to integrin avb6 and use of same to treat cancer
01/07/16Detection and treatment of pancreatic, ovarian and other cd70 positive cancers
12/31/15Anti-ntb-a antibodies and related compositions and methods
11/26/15Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
11/12/15Self-stabilizing linker conjugates
10/29/15Antibody drug conjugates (adc) that bind to 191p4d12 proteins
10/08/15Cd19 binding agents and uses thereof
09/03/15Novel binder-drug conjugates (adcs) and use of same
08/27/15Treatment of sickle cell disease and inflammatory conditions
08/27/15Antibody drug conjugates (adc) that bind to 158p1d7 proteins
05/28/15Cd33 antibodies and use of same to treat cancer
05/28/15N-carboxyalkyl-auristatin and use thereof
03/19/15Dr5 ligand drug conjugates
02/12/15Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the c-terminus
01/29/15Novel binder-drug conjugates (adcs) and use thereof
01/22/15New antibody drug conjugates (adcs) and the use thereof
12/25/14Detection and treatment of cd30+ cancers
08/28/14Intact mass determination of protein conjugated agent compounds
08/07/14Monomethylvaline compounds capable of conjugation to ligands
06/26/14Humanized anti-cd70 binding agents and uses thereof
04/17/14Variant target binding agents and uses thereof
03/27/14Variant target binding agents and uses thereof
03/20/14N-carboxyalkylauristatins and use thereof
02/20/14Auristatin drug linker conjugates
01/30/14Beta-glucuronide-linker drug conjugates
01/30/14Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
10/24/13Dr5 ligand drug conjugates
06/20/13Novel auristatin derivatives and use thereof
05/23/13Methods of inhibition of protein fucosylation in vivo using fucose analogs
05/16/13Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus
01/31/13Targeted pyrrolobenzodiazapine conjugates
01/24/13Combination therapy with antibody-drug conjugates
01/24/13Nucleic acids encoding humanized anti-cd40 antibodies
Patent Packs
12/20/12Methods for screening antibodies
11/22/12Cd19 binding agents and uses thereof
11/22/12Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
11/15/12Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
10/04/12Treatment of b-cell cancers with anti-cd70 antibody-drug conjugates
07/19/12Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
06/14/12Monomethylvaline compounds capable of conjugation to ligands
06/14/12Monomethylvaline compounds capable of conjugation to ligands
06/07/12Monomethylvaline compounds capable of conjugation to ligands
06/07/12Monomethylvaline compounds capable of conjugation to ligands
06/07/12Monomethylvaline compounds capable of conjugation to ligands
05/03/12Beta-glucuronide-linker drug conjugates
02/23/12Humanized anti-cd70 binding agents and uses thereof
02/09/12Monomethylvaline compounds capable of conjugation to ligands
02/09/12Monomethylvaline compounds capable of conjugation to ligands
Patent Packs
02/02/12Monomethylvaline compounds capable of conjugation to ligands
02/02/12Monomethylvaline compounds capable of conjugation to ligands
01/05/12Monomethylvaline compounds capable of conjugation to ligands
01/05/12Monomethylvaline compounds capable of conjugation to ligands
12/22/11Cd19 binding agents and uses thereof
12/08/11Detection and treatment of pancreatic, ovarian and other cancers
11/17/11Toxin conjugated eph receptor antibodies
11/03/11Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
06/23/11Anti-cd70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders
04/28/11Partially loaded antibodies and methods of their conjugation
03/17/11Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
02/17/11Methods of treating neoplastic, autoimmune and inflammatory diseases
01/27/11Auristatin drug linker conjugates
10/14/10Methods of treating drug-resistant cancers
09/23/10Cd30 binding agents and uses thereof
08/26/10Methods of treating neoplastic, autoimmune and inflammatory diseases
07/22/10Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
06/24/10Methods for augmenting an immune response using anti-cd40 antibodies
06/24/10Variant target binding agents and uses thereof
06/24/10Treatment of renal cell carcinoma with anti-cd70 antibody-drug conjugates
06/17/10Treatment of b-cell cancers with anti-cd70 antibody-drug conjugates
05/27/10Treatment of psoriatic arthritis with anti-cd70 antibody
03/11/10Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
12/31/09Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
12/24/09Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
12/10/09Methods of using cd40 binding agents
12/10/09Toxin conjugated eph receptor antibodies
11/12/09Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
09/17/09Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
05/28/09Cd19 binding agents and uses thereof
Social Network Patent Pack
03/19/09Anti-cd70 antibody and its use for the treatment of cancer and immune disorders
02/19/09Monomethylvaline compounds capable of conjugation to ligands







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Seattle Genetics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Seattle Genetics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';